Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group
scientific article
Author/s
author: Jean-Yves Blay, Axel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, Emmanuelle Bompas, Didier Cupissol, Jérôme Fayette, Antoine Adenis, Sylvie Chabaud, Cécile Guillemet, Catherine Delbaldo, Patrice Berthaud, David Pérol
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.